The Association for Research in Vision and Ophthalmology (ARVO) is the leading international research organization for the vision research community. The annual meeting is the largest meeting of basic and clinical researchers from around the world who come to together to share novel and cutting-edge breakthroughs in eye and vision research. Wills Eye faculty, staff and trainees actively participate at ARVO each year, contributing to new knowledge and ideas to advance prevention and treatment of eye diseases and patient care.
This year, at the 2019 ARVO Annual Meeting in Vancover, British Columbia, Wills Eye faculty, staff, fellows, residents and medical students will give 29 presentations and are co-authors/collaborators on an additional 19 presentations.
| SESSIONS | TIME AND LOCATION | PRESENTERS | TOPIC |
|---|---|---|---|
| PAPER SESSIONS | |||
| Sunday April 28, 2019 | |||
| RE: Emerging AMD Therapeutics | 3:15 – 3:30 PM Room 55 Presentation # 971 | Freeman W, Bandello F, Souied E, Guymer R, Garg S , Chen F, Rich R, Holz F, Li Y, Kerr K, Lopez F | Phase 2b Study of Brimonidine DDS: Potential Novel Treatment for Geographic Atrophy |
| Tuesday April 30, 2019 | |||
| GL: Visual Fields, Psychophysics, and Electrophysiology | 8:45 – 9:00 AM Room 210 Presentation # 2855 | Wang M, Shen L, Pasquale L, Boland M, Wellik S, Moraes C, Myers J , Bex P, Saeedi O, Baniasadi N, Wang H, Li D, Tichelaar J, Elze T | Central Visual Field Loss Patterns in Glaucoma |
| AP: Non-Melanoma Tumors: Genetics and Therapeutics | 9:15 – 9:30 AM Room 198 Presentation # 2778 | Lim L, Dalvin L, Lezama D, Chang M, Mashayekhi A, Shields C | Intravitreal melphalan for vitreoretinal lymphoma |
| GL: Visual Fields, Psychophysics, and Electrophysiology | 9:30 – 9:45 AM Room 210 Presentation # 2858 | Tichelaar J, Wang M, Shen L, Pasquale L, Boland M, Wellik S, Moraes C, Myers J , Bex P, Saeedi O, Baniasadi N, Li D, Wang H, Elize T | Defect Classes of Visual Field Measurement in Glaucoma |
| GL: Laser Therapy | 10:15 – 10:30 AM Room 205 Presentation # 2829 | Bonafede L, Tran J, Hark L, Sanvicente C, Zhang Q, Costello R, Katz L | Beliefs and Attitudes of Ophthalmologists Regarding Selective Laser Trabeculoplasty as First Line Therapy for Glaucoma |
| RE: Update on Endophthalmitis | 12:30 – 12:45 PM Room 229 Presentation # 3255 | Lee C, Kasi S , Hong B, Ali F, Akleswaran L, Garg S , Gelder R | Genomic and gene expression analyses of pathogens in post-surgical endophthalmitis |
| EY: Mechanisms and biomechanics of traumatic retinal hemorrhage in children | 3:20 – 3:35 PM Room 265 Presentation # 3903 | Levin, A | Retinal hemorrhage: Science versus speculation |
| Wednesday May 1, 2019 | |||
| EY: Optic Neuropathy | 10:30 – 10:45 AM Room 322 Presentation # 4806 | Yu-Wai-Man P, Moster M , Sadun A, Klopstock T, Clermont C, Newman N, Sergott R , Carelli V, Chevalier C, Blouin L, Taiel M, Katz B Sahel J | rAAV2/2-ND4 for the Treatment of Leber Hereditary Optic Neuropathy (LHON): 72-Week Data from the REVERSE Phase III Clinical Trial |
| POSTER SESSIONS | |||
| Sunday April 28, 2019 | |||
| CL: AMD screening, risk factors and consequences | 8:00 – 9:45 AM West Exhibition Hall 10 Poster # A0143 | Sivalingam M, Gervasio K, Wu C, Matsunaga D, Uhr J, Obeid A, Wibbelsman T, Levine H, Pandit R, Jenkins T, Xu D, Hsu J, Ho A | Sociodemographic disparities in presenting visual acuity of neovascular age related macular degeneration patients |
| RE: AMD anti-VEGF I | 8:00 – 9:45 AM West Exhibition Hall 11 Poster # A0260 | Hsu J, Obeid A, Mellen P, Wibbelsman T, Konkoly M, Velez M, Calem D, Sioufi K, Su D, Storey P, Klufas M, Spirn M, Regillo C, Ho A | Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab |
| RE: AMD anti-VEGF II | 8:00 – 9:45 AM West Exhibition Hall 12 Poster # A0317 | Li V, Gabriel I, Li M, Antoszyk A, Baker C, Dugel P, Goldberg R, Heier J, Ho A , Pollack J, Wykoff C, Vavvas D, Li W | Treatment and Management of Neovascular AMD: Impact on Patients |
| GL: Laser Therapy | 1:00 – 2:45 PM West Exhibition Hall 45 Poster # B0165 | Wu C, Kuley B, Zheng C, Lin M, Moster S, Schmidt C, Moster M, Pro M, Lee D | Outcomes of selective laser trabeculoplasty after prior incisional surgery for open-angle glaucoma |
| GL: Laser Therapy | 1:00 – 2:45 PM West Exhibition Hall 45 Poster # B0167 | Copparam S, Kuley B, Zheng C, Lin M, Moster S, Schmidt C, Moster M, Lee D, Pro M | Outcomes of repeat selective laser trabeculoplasty for open-angle glaucoma |
| IM: Clinical and epidemiological aspects of infection | 1:00 – 2:45 PM West Exhibition Hall 49 Poster # B0341 | Dohse N , Wibbelsman T, Rapuano S, Hammersmith K, Nagra P, Rapuano C, Syed Z | Microbial Keratitis After Penetrating and Endothelial Keratoplasty |
| AP: Clinical Melanoma. Therapy and Complications | 1:00 – 2:45 PM West Exhibition Hall 46 Poster # B0199 | Chang M, Dalvin L, Lim L, Mazloumi M, Yaghy A, Mashayekhi A, Shields C | Prophylactic Intravitreal Bevacizumab after Plaque Radiotherapy for Uveal Melanoma: Analysis of 1311 Eyes of 1310 Patients by Age |
| AP: Clinical Melanoma. Therapy and Complications | 1:00 – 2:45 PM West Exhibition Hall 46 Poster # B0203 | Yanghy A, Dalvin L, Yu M, Mazloumi M, Shields C | Photoreceptor Morphology and Correlation with Subretinal Fluid Chronicity Associated with Choroidal Nevus |
| LE: Cataract Surgery I | 1:00 – 2:45 PM West Exhibition Hall 38 Poster # A0487 | Moustafa G, Borkar D , Eton E, Koulisis N, Kloek C | Predictors of Non-adherence to Follow-up after Cataract Surgery: Results from the PCIOL Study |
| AP: Clinical Melanoma. Therapy and Complications | 1:00 – 2:45 PM West Exhibition Hall 38 Poster # A0487 | McCannel T, Bhavsar A, Capone A, Demirici H, Kim I, Marr B, Rich C, Schefler A, Shields C | Two-year results of a phase 1b/2 open-label clinical trial of AU-011 for the treatment of small to medium choroidal melanoma |
| CL: Diabetic eye disease | 3:00 – 4:45 PM West Exhibition Hall 68 Poster # A0028 | Nezhad G, Vardanjani H, Razeghinejad M , Janghorbani M | Discrepancies in the epidemiology of diabetic retinopathy among diabetes clinics, eye clinic, and population-based studies: A Systematic Review, and Meta-Analysis |
| RE: AMD clinical research II | 3:00 – 4:35 PM West Exhibition Hall 71 Poster # A0211 | Soares R, Mellen P, Garrigan H, Obeid A, Wibbelsman T, Borkar D, Ho A, Hsu J | Outcomes of Eyes Lost to Follow-Up with Neovascular Age Related Macular Degeneration Receiving Intravitreal Anti-VEGF |
| Monday April 29, 2019 | |||
| RE: Endophthalmitis: clinical | 11:15 AM – 1:00 PM West Exhibition Hall 136 Poster # B0041 | Patel S, Storey P, Pancholy M, Obeid A, Wibbelsman T, Levin H, Hsu J, Garg S, Dunn J, Vander J | The utility of vitreous cultures in the management of endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents |
| RE: Endophthalmitis: clinical | 11:15 AM – 1:00 PM West Exhibition Hall 136 Poster # B0052 | Levin H, Storey P, Pancholy M, Patel S, Wibbelsman T, Obeid A, Ho A | Endophthalmitis following cataract surgery: visual outcomes and culture results |
| CL: Glaucoma risk factors, progression, and management | 11:15 AM – 1:00 PM West Exhibition Hall 134 Poster # A0531 | Jiang A, Jordan C, Murphy J , Sanvicente C , Fudemberg S | Cost sharing of glaucoma medications: are patients able to predict the amount of their financial obligation? |
| LV: Visual Impairment - Measures of Visual Function | 11:15 AM – 1:15 PM West Exhibition Hall 129 Poster # A0101 | Cideciyan A, Jacobson S, Drack A, Ho A , Garafalo A, Roman A, Schwartz M, Biasutto P, Wit W, Cheetham M, Adamson P, Rodman D, Zaeytijd J, Cauwenbergh C, Leroy B, Russell S | CEP290-associated LCA due to a photoreceptor cilium defect treated with an intravitreal antisense oligonucleotide results in improved vision |
| RE: Diabetic Macular Edema Clinical Research | 4:00 – 5:45 PM West Exhibition Hall 179 Poster # B0176 | Kuley B , Storey P, Pancholy M, Obeid A, Murphy J , Goodman J , Wibbelsman T, Regillo C, Chiang A | Ocular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone |
| AP: Retinoblastoma | 4:00 – 5:45 PM West Exhibition Hall 170 Poster # A0380 | Camp D, Dalvin L, Schwendeman R, Lim L, Shields C | Neonatal Retinoblastoma: Analysis of Treatment Outcomes in the Pre-Chemotherapy, Intravenous Chemotherapy, and Intra-arterial Chemotherapy Eras |
| GL: Clinical Studies | 4:00 – 5:45 PM West Exhibition Hall 172 Poster # A0557 | Ustaoglu M, Shiuey E , Sanvicente C, Razeghinejad R, Katz L, Myers J, Lee D | The Efficacy and Safety Profile of Netarsudil 0.02% in Glaucoma Treatment: Real-World Outcomes |
| GL: Visual Fields, Psychophysics, and Electrphysiology | 4:00 – 5:45 PM West Exhibition Hall 174 Poster # A0624 | Li D, Shen L, Pasquale L, Boland M, Wellik S, Moraes D, Myers J , Bex P, Saeedi O, Baniasadi N, Wang H, Tichelaar J, Elze T, Wang M | Baseline Visual Field (VF) Patterns are Predictive of Global and Central Loss in 24-2 Visual Fields |
| GL: IOP Measurement | 4:00 – 5:45 PM West Exhibition Hall 173 Poster # A0593 | Price J, Levin A | When is iCare High Care? |
| CL: Ocular Trauma | 4:00 – 5:45 PM West Exhibition Hall 176 Poster # B0009 | Ramsay C, Murchison A, Bilyk J | Prevalence of pediatric eye trauma and ER usage rates: pediatric ophthalmic trauma presenting to a an ophthalmic-only ER from 2012-2013. |
| Tuesday April 30, 2019 | |||
| AP: Non-Melanoma, Non-Retinoblastoma Intraocular Pathology & Retinopathy | 11:45 AM – 1:30 PM West Exhibition Hall 244 Poster # A0591 | Acaba-Berrocal L , Williams B, Di-Nicola M, Alvarez J, Shields J, Shields C | Adenoma and adenocarcinoma of the retinal pigment epithelium: clinical and imaging characteristics, treatment options and histopathologic findings in 51 consecutive patients |
| IM: Uveitis and scleritis - clinical therapeutics and checkpoint inhibitors | 11:45 AM – 1:30 PM West Exhibition Hall 243 Poster # A0551 | Mckay K, Borkar D , Sevgi D, Papaliodis G, Sobrin L | Modified Anterior Sub-Tenon’s Periocular Steroid Injection for Treatment of Intraocular Inflammation and Cystoid Macular Edema |
| CL: Consequences of vision impairment | 11:45 AM – 1:30 PM West Exhibition Hall 248 Poster # B0060 | Wizov S , Shiuey E, Sanvicente C , Leiby B, Tran J, Waisbourd M, Myers J, Katz L , Moster M, Spaeth G | Risk of auto accidents in patients with moderate-stage glaucoma |
| GL: Surgery and Wound Healing I | 11:45 AM – 1:30 PM West Exhibition Hall 252 Poster # B0282 | Myers J, Zheng C, Moster S, Lin M | Short term outcomes of transconjunctival ab externo XEN 45 Gel Stent implantation |
| AP: Non-Melanoma, Non-Retinoblastoma Intraocular Pathology & Retinopathy | 11:45 AM – 1:30 PM West Exhibition Hall 244 Poster # A0584 | Dalvin L, Lim L, Lezama D, Mazloumi M, Chang M, Mashayekhi A, Shields C | Survival Times in Patients with Vitreoretinal Lymphoma. Analysis of 95 Patients at a Single Ocular Oncology Center |
| CL: Retinal disease epidemiology | 2:45 – 4:30 PM West Exhibition Hall 270 Poster # A0460 | Pandit R , Wibbelsman T , Jenkins T , Xu D , Obeid A , Ho A | Factors predicting distribution and practice patterns of retina providers across the United States (US) |
| CL: Retinal disease epidemiology | 2:45 – 4:30 PM West Exhibition Hall 270 Poster # A0472 | Levin A, Guimarães T, Ibañez M, Capasso J | Stargardt Misdiagnosis: How Ocular Genetics Helps |
| CL: Retinal disease epidemiology | 2:45 – 4:30 PM West Exhibition Hall 270 Poster # A0466 | Uhr J, Obeid A, Wibbelsman T, Wu C, Hsu J | Incidence and Timing of Delayed Retinal Breaks Following Acute Symptomatic Posterior Vitreous Detachment |
| RE: Retinal Vascular Diseases I | 2:45 – 4:30 PM West Exhibition Hall 274 Poster # B0113 | Wibbelsman T, Calem D , Obeid A, Mellen P, Konkoly M, Velez M , Sioufi K, Borkar D, Pandit R, Klufus M, Hsu J, Regillo C, Ho A, Gupta O, Spirn M | Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion |
| RE: Retinal Vascular Diseases I | 2:45 – 4:30 PM West Exhibition Hall 274 Poster # B0110 | Khoo C, Udyaver S, Dalvin L, Lim L, Atalay H, Mazloumi M, Shields C | Factors predictive of retinal detachment resolution in Coats disease: Analysis of 187 eyes in 184 patients at a single center |
| Wednesday May 1, 2019 | |||
| CL: Prevalence of vision impairment | 8:15 – 10:00 AM West Exhibition Hall 302 Poster A0341 | Wey S, Ramsay C, Li L, Lee D | Effectiveness of an educational intervention on glaucoma for a Mandarin-speaking population in Philadelphia: A proof of concept study |
| EY: Amblyopia- Vision Screening and Epidemiology | 8:15 – 10:00 AM West Exhibition Hall 300 Poster # A0309 | Vagge A, La Mattina K, Nelson L | Accuracy of the Red Reflex Test to Detect Unequal Refractive Error |
| RE: Macular Diseases Excluding AMD | 10:15 AM – 12:00 PM West Exhibition Hall 333 Poster # A0510 | Xu D, Obeid A, Levin H, Matsunaga D, Gervasio K, Jenkins T, Pandit R, Ho A | Etiology, treatment and visual outcomes of patients with choroidal neovascularization under the age of 50 |
| GL: Trabecular Meshwork and Ciliary Body | 10:15 AM – 12:00 PM West Exhibition Hall 336 Poster # B0563 | Moster S, Zheng C, Lin M, Copparam S, Lee D | Surgical outcomes of trabecular micro-bypass (iStent) surgery performed by ophthalmology resident trainees compared to attending surgeons |
| LV: Visual Impairment and Patient Reported Outcomes | 10:15 AM – 12:00 PM West Exhibition Hall 331 Poster # A0373 | Harley M, Malik K , Sanvicente C, Spaeth G, Lee D | The Relationship between Patients’ Clinical Behavior, Physician Impressions and Glaucoma Progression |
| PH: Diabetic retinopathy, cytokines and growth factors | 3:00 – 4:45 PM West Exhibition Hall 369 Poster # B0054 | Klufas M, Chiang A, Hill L, Tsuboi M, Stoilov I | Patients ultra-responsive to ranibizumab: rates of ≥4-step improvement in diabetic retinopathy severity in DRCR.net Protocol S |
| Thursday May 2, 2019 | |||
| EY: Orbit and Thyroid eye Disease | 8:00 – 9:45 AM West Exhibition Hall 409 Poster # B0197 | Gervasio K, Godfrey K, Winebrake J, Lee M, Sippel K, Lai E, Lelli G | Utility of PROSE in thyroid eye disease patients with recurrent proptosis after orbital decompression |
| GL: Surgery and Wound Healing II | 10:15 AM – 12:00 PM West Exhibition Hall 432 Poster # B0096 | Dugan C, Ustaoglu M, Zheng C, Lin M, Moster S, Sanvicente C, Moster M | Outcomes of Ahmed glaucoma valve implantation modified with viscoelastic anterior chamber fill |